Trial in progress: A phase 1-2 multicenter, open-label, dose-escalation and dose-expansion study to evaluate the safety, pharmacokinetics, pharmacodynamics, and antitumor activity of ABN401 in patients with advanced solid tumors.

Citation

• Lee, D. H., Roohullah, A., Cho, B. C., Lemech, C. R., de Souza, P. L., Millward, M., . . . Han, J. -Y. (2021). Trial in progress: A phase 1-2 multicenter, open-label, dose-escalation and dose-expansion study to evaluate the safety, pharmacokinetics, pharmacodynamics, and antitumor activity of ABN401 in patients with advanced solid tumors.. Journal of Clinical Oncology, 39(15_suppl), tps3157. doi:10.1200/jco.2021.39.15_suppl.tps3157

Digital Object Identifier (doi)

• 10.1200/jco.2021.39.15_suppl.tps3157

Web Of Science Accession Number

Start Page

• tps3157

End Page

• tps3157

Volume

• 39

Issue

• 15_suppl

Place Of Publication

Abstract

UOW Authors

•   De Souza, Paul (external author)

Publication Date

• 2021

Publisher

• American Society of Clinical Oncology (ASCO) 

Published In

• Journal of Clinical Oncology  Journal

Citation

• Lee, D. H., Roohullah, A., Cho, B. C., Lemech, C. R., de Souza, P. L., Millward, M., . . . Han, J. -Y. (2021). Trial in progress: A phase 1-2 multicenter, open-label, dose-escalation and dose-expansion study to evaluate the safety, pharmacokinetics, pharmacodynamics, and antitumor activity of ABN401 in patients with advanced solid tumors.. Journal of Clinical Oncology, 39(15_suppl), tps3157. doi:10.1200/jco.2021.39.15_suppl.tps3157

Digital Object Identifier (doi)

• 10.1200/jco.2021.39.15_suppl.tps3157

Web Of Science Accession Number

Start Page

• tps3157

End Page

• tps3157

Volume

• 39

Issue

• 15_suppl

Place Of Publication